Navigation Links
Reportlinker Adds China Pharmaceutical Market Overview
Date:12/8/2010

a, 2010 190

Table 56: China - Roche's China-based M&A activities, 1995-2010 193

Table 57: China - Shandong Qilu Pharma's top 10 selling drugs ($m) and their NRDL status (China and Hong Kong), 2010 194

Table 58: China - Shandong Qilu Pharma's sales, R&D and manufacturing infrastructure data compared with the top 2 domestic companies in China, 2010 195

Table 59: China - Merck & Co.'s top 10 selling drugs ($m) and their NRDL status (China and Hong Kong), 2010 197

Table 60: China - Merck & Co.'s sales, R&D and manufacturing infrastructure data compared with other top 8 multinational companies in China, 2010 199

Table 61: China - Jiangsu Yangzijiang Pharma's top 10 selling drugs ($m) and their NRDL status (China and Hong Kong), 2010 202

Table 62: China - Jiangsu Yangzijiang Pharma's sales, R&D and manufacturing data compared with the top 2 domestic companies, 2010 203

Table 63: China - Novartis's top 10 selling drugs ($m) and their NRDL status (China and Hong Kong), 2010 205

Table 64: China - Novartis drugs recently listed on the NRDL, 2009 206

Table 65: China - Novartis's sales, R&D and manufacturing infrastructure data compared with other top 8 multinational companies in China, 2010 207

Table 66: China - Novartis's China-based M&A activities, 2008-2010 210

Table 67: China - GlaxoSmithKline's top 10 selling drugs ($m) and their NRDL status (China and Hong Kong), 2010 211

Table 68: China - GlaxoSmithKline's sales, R&D and manufacturing infrastructure data compared with other top 8 multinational companies in China, 2010 212

Table 69: China - GlaxoSmithKline's China-based M&A activities, 2008-2010 215

Table 70: Currency exchange rates, 2010 239

Table 71: ATC (anatomical therapeutic chemical) classification codes assigned to a given therapy area within the prescription pharmaceutical market 240

List of Figures

'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Reportlinker Adds Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions
2. Reportlinker Adds Gilead Sciences: PharmaVitae Profile
3. Reportlinker Adds Generics Market Outlook: 2015
4. Reportlinker Adds Russia Pharmaceutical Market Overview Pharma Companies Target Russia Despite the Challenges it Presents
5. Reportlinker Adds Monoclonal Antibodies: 2010
6. Reportlinker Adds Asia-Pacific Orthopedic Devices Market Outlook to 2016
7. Reportlinker Adds Astellas Pharma Inc.: PharmaVitae Profile
8. Reportlinker Adds Prostate Cancer - Spain Drug Forecasts and Treatment Analysis to 2020
9. Reportlinker Adds Global Generic Pharmaceuticals Industry Report
10. Reportlinker Adds Prostate Cancer - Japan Drug Forecasts and Treatment Analysis to 2020
11. Reportlinker Adds Global Syringes (Disposable and Reusable) Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014  Actavis plc ... the Company has received a complete response letter ... for its New Drug Application (NDA) for the ... the treatment of hypertension.   Photo - ... are disappointed in the receipt of a complete ...
(Date:12/24/2014)... 2014 /PRNewswire/  -- Tianyin Pharmaceutical Inc. (NYSE Amex: ... specializes in the patented biopharmaceutical, modernized traditional Chinese ... (API) released unaudited preliminary financial results for the ... Fiscal Year 2015 Ended September 30, 2014 Financial ... with $14.7 million in 1Q14 with gross margins ...
(Date:12/24/2014)... , Dec. 24, 2014 Soligenix, ... late-stage biopharmaceutical company developing products that address unmet ... and biodefense, announced today that on December 24, ... offering. The Company raised approximately $2.3 ... intends to use the net proceeds from the ...
Breaking Medicine Technology:Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3
... PHOENIX, Sept. 4 Zila, Inc.,s (Nasdaq: ZILA ... of,abnormalities which can lead to oral cancer, has been ... of Cetuximab (ERBITUX(R)), a,leading cancer therapeutic for head and ... and distributed by Bristol-Meyers Squibb (NYSE:,BMY). The NIH ...
... Meets Primary and All Secondary Endpoints, San ... NGSX ), a biopharmaceutical company focused on developing ... from,its second pivotal study of NGX-4010, the Company,s ... -- in patients with postherpetic,neuralgia (PHN). The study, ...
Cached Medicine Technology:Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX 2Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX 3NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia 2NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia 3NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia 4NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia 5NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia 6NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia 7
(Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
(Date:12/25/2014)... 2014 The click strand ... strength and durability. Today, the business announces a ... valid until Jan. 30, 2015. , Click strand ... hardwood. BambooFlooringChina.com is a well-known brand in the ... to find a reliable bamboo flooring supplier. , ...
(Date:12/25/2014)... 2014 Product liability lawsuits filed in ... ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal ... issued in the U.S. District Court, Northern District of ... open conference on January 7, 2015, at the Paul ... West Palm Beach, Florida. The Conference is scheduled to ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying ... of discounted prom dresses, most of which are priced ... the company, the promotion is valid until Jan. 22, ... the UK market. , The prom dresses in this ... styles: A-line strapless, empire strapless chiffon, one shoulder, floor-length, ...
(Date:12/25/2014)... sells many bamboo products and the business is famous ... announces big discounts on its bamboo mats , which ... the world’s leader in bamboo flooring. According to the ... 2015. , The bamboo mats are made from well-treated ... the bamboo strips for the mats are boiled and ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
... P&C Industry Transactions Gateway Multiplies Direct Connectivity with ... States Move to Adopt eBill Regulations CONCORD, ... Property and Casualty industry supplier of EDI Gateway ... providers and payers nationwide. Network expansion enables Jopari ...
... O,Rourke, MD, Associate Professor of Neurosurgery at the University ... to accurately predict the specific genetic mutation that caused ... magnetic resonance imaging (MRI). The researchers presented their findings ... 100th Annual Meeting 2009. , "The field of cancer ...
... in poor areas more of an issue than youngsters, tastes, ... nutrition may be more an issue of supply than demand ... A new study found that children in these rural areas ... research shows these products are not readily available and could ...
... 2009) New research published in the April issue ... Surgeons suggests that, among surgeons inexperienced in laparoscopic ... less time to learn and results in improved outcomes ... with freehand laparoscopy. , Laparoscopic suturing a ...
... April 15, 2009, ten members of the American Society of ... attended more than a dozen meetings scheduled with key Congressional ... of transplant related issues on Capitol Hill. The Fly ... , AST discussed healthcare ...
... In study on rats, protection eludes those exposed as ... and the estrogen hormone they produce might help protect ... caused by the active ingredient in marijuana, Louisiana State ... , The protection did not seem to apply, ...
Cached Medicine News:Health News:Jopari Further Expands Nationwide Medical Billing Network Connectivity for Workers' Comp and Auto Providers and Payers 2Health News:Jopari Further Expands Nationwide Medical Billing Network Connectivity for Workers' Comp and Auto Providers and Payers 3Health News:First noninvasive technique to accurately predict mutations in human brain tumors 2Health News:Kids and Veggies: Offer Them and They Will Eat 2Health News:Robot improves suture proficiency more rapidly for surgeons inexperienced in laparoscopic techniques 2Health News:Robot improves suture proficiency more rapidly for surgeons inexperienced in laparoscopic techniques 3Health News:AST Leaders Fly to Capitol Hill to Garner and Secure Support for Transplantation Initiatives 2Health News:Estrogen May Combat Marijuana's Effect on Cognition 2
... Size: 5.0 x 2.5 x 80 mm. Half ... by Harvey A. Lincoff, M.D. has been modified ... design. The material is a closed cell sponge ... with rounded edges to minimize scleral intrusion. These ...
... mm. Storz offers the original Scleral ... A. Lincoff, M.D. The material is ... non-toxic and non-antigenic. Implants are soft ... intrusion. These implants are packaged sterile ...
For use under curved implants. Indications: When additional buckling is required in the meridional direction. Overall length: 15.0 mm....
For use under silicone strips E5381 610, E5381 611 and E5381 710. Indications: When higher buckle is required. Overall length: 6.1 mm....
Medicine Products: